pharmaceutical
Taking Asprin? Don’t Stop
Medical News: Aspirin Holiday Is a Bad Idea – in Cardiovascular, Prevention from MedPage Today
A case-control study found that patients taking low-dose aspirin for secondary prevention who had recently discontinued the drug had a higher risk of nonfatal myocardial infarction than those who continued to take the aspirin.
Prescription Drug OD Deaths Up in Florida
Deaths in Florida involving prescription drugs in 2009 were four times as common as those related to illicit drugs, with alprazolam (Xanax) joining opioids among the top killers, the CDC reported.
From 2003 to 2009, the death rate in Florida from overdoses of prescription drugs increased 84.2%, from 7.3 to 13.4 per 100,000 population, according to data from the Florida Medical Examiners Commission analyzed by the CDC in the July 8 issue of Morbidity and Mortality Weekly Report.
Time to tighten up your anxiety/depression underwriting guidelines? How about script checks at lower amounts? Can you differentiate between the applicant who wants to off himself versus plain vanilla anxiety?
Generic Lipitor Coming Soon
Namenda in the News
Azilsartan Medoxomil (Edarbi)
The FDA has approved azilsartan medoxomil (Edarbi), an oral angiotensin II receptor blocker (ARB) for hypertension, expanding the ranks of ARBs now available to U.S. patients.
TAK-491 would have been a better brand name IMHO.
Statins for Everyone – (not yet)
Doctors should be cautious about prescribing statin drugs for primary prevention in people at low risk of cardiovascular events — because of shortcomings in the evidence to support such use, a Cochrane review warned.
Vorapaxar Phase III Update
Whoops.
The novel antithrombotic vorapaxar causes intracranial hemorrhage in patients with a history of stroke, Merck announced, explaining why stroke survivors were dropped from trials of the experimental drug.
Vilazodone (Viibryd) = New Antidepressant
Medical News: FDA Approves New Antidepressant – in Product Alert, Prescriptions from MedPage Today
Vilazodone (Viibryd) has been approved for treatment of major depression, the FDA announced.
lifeunderwriter.net 
You must be logged in to post a comment.